AiCure unveils data dashboards for clinical trials

By The Science Advisory Board staff writers

December 8, 2020 -- Clinical trial artificial intelligence (AI) technology developer AiCure has introduced AiCure Data Intelligence, a data dashboard designed to enable clinical trial sponsors to track patient behavior and site performance.

Available via a data hub, Data Intelligence collects insights provided by the firm's AI platform to enable assessment of trial and site performance, patient dosing and symptoms, intervention success rate, and other data, according to the vendor. These dashboards also enable predictive analytics, AiCure said.

Data Intelligence can be configured by sponsors to examine the specific data views they need, AiCure said.

AstraZeneca, partner for lung cancer diagnosis
AstraZeneca has partnered with deep-learning algorithm developer to integrate artificial intelligence solutions for the early detection of lung...
BioNTech, InstaDeep form AI lab
BioNTech and InstaDeep will form a joint artificial intelligence (AI) lab as part of a multiyear strategic collaboration.
Iktos, Merck collaborate on AI for new drug designs
Artificial intelligence (AI) firm Iktos plans to collaborate with pharmaceutical giant Merck on AI for new drug design.
BioSymetrics, Janssen, Sema4 use AI to predict COVID-19
BioSymetrics, Sema4, and Janssen Pharmaceuticals will use artificial intelligence (AI) to predict the onset and severity of COVID-19 among different populations.
Cerevel, Cyclica partner on AI-based drug discovery
Cerevel Therapeutics and Cyclica have announced a research collaboration that will use artificial intelligence (AI) to develop new neurological medicines.

Copyright © 2020

Science Advisory Board on LinkedIn
Science Advisory Board on Facebook
Science Advisory Board on Twitter